...
首页> 外文期刊>Journal of gastroenterology >Mechanism of interdigestive migrating motor complex in conscious dogs.
【24h】

Mechanism of interdigestive migrating motor complex in conscious dogs.

机译:有意识的狗的消化内迁移运动复合物的机制。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The migrating motor complex (MMC) is well characterized by the appearance of gastrointestinal contractions in the interdigestive state. This study was designed to clarify the mechanisms of gastric MMC (G-MMC) and intestinal MMC (I-MMC) in conscious dogs. METHODS: Five strain gauge transducers were implanted on the stomach and intestine. To investigate the correlation between luminal 5-HT and phase III contractions, gastric and duodenal juices were collected during the MMC cycle. The 5-HT concentrations in gastric and duodenal juice were measured by HPLC. To investigate whether luminal 5-HT initiates MMC, 5-HT (10(-8)-10(-6) M, 10 ml) was administered into the duodenum 20 min after gastric phase III. To investigate the involvement of 5-HT(3) or 5-HT(4) receptors in mediating G-MMC and I-MMC, 5-HT(3) antagonists (ondansetron) or 5-HT(4) antagonists (GR 125,487) were infused for 120 min. RESULTS: Luminal administration of 5-HT (10(-6) M) initiated duodenal phase II followed by G-MMC and I-MMC with a concomitant increased release of plasma motilin. The duodenal 5-HT concentration was significantly increased during phase II (59 +/- 9 ng/ml) and phase III (251 +/- 21 ng/ml) compared to that of phase I (29 +/- 5 ng/ml). On the other hand, the 5-HT content in the stomach was not significantly changed throughout the MMC cycle. Intravenous infusion of motilin (0.3 microg/kg/h) increased the luminal 5-HT content and induced G-MMC and I-MMC. 5-HT(4) antagonists significantly inhibited both G-MMC and I-MMC, while 5-HT(3) antagonists inhibited only G-MMC. CONCLUSION: It is suggested that the MMC cycle is mediated by a positive feedback mechanism via the interaction between motilin and 5-HT.
机译:背景:迁移运动复合物(MMC)的特征是消化不良状态下胃肠道收缩的出现。这项研究旨在阐明清醒犬的胃MMC(G-MMC)和肠MMC(I-MMC)的机制。方法:将五个应变仪换能器植入胃和肠。为了研究5-HT腔和III期收缩之间的相关性,在MMC周期中收集了胃液和十二指肠液。通过HPLC测量胃和十二指肠汁中的5-HT浓度。为了研究腔内5-HT是否引发MMC,在胃III期后20分钟将5-HT(10(-8)-10(-6)M,10 ml)注入十二指肠。若要调查5-HT(3)或5-HT(4)受体参与介导G-MMC和I-MMC,5-HT(3)拮抗剂(翁丹西酮)或5-HT(4)拮抗剂(GR 125,487 )注入120分钟。结果:5-HT(10(-6)M)的光明给药开始了十二指肠期II,随后是G-MMC和I-MMC,伴随着血浆胃动素释放的增加。与阶段I(29 +/- 5 ng / ml)相比,阶段II(59 +/- 9 ng / ml)和阶段III(251 +/- 21 ng / ml)的十二指肠5-HT浓度显着增加。 )。另一方面,在整个MMC周期中,胃中5-HT的含量没有显着变化。静脉注射胃动素(0.3 microg / kg / h)增加了腔内5-HT含量并诱导了G-MMC和I-MMC。 5-HT(4)拮抗剂显着抑制G-MMC和I-MMC,而5-HT(3)拮抗剂仅抑制G-MMC。结论:MMC周期是由正反馈机制通过胃动素与5-HT的相互作用介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号